Parkway Life Real Estate Investment Trust (C2PU) Fair Value & Analysis
Real Estate · SG · Market cap 2.7B SGD
Fair value as of: Jul 4, 2026
From 25 valuation models · updated today
Share price +4.1% over the past month.
Price vs Fair Value (12 months)
12‑month range 3.83 SGD – 4.30 SGD · fair‑value band 1.17 SGD – 2.81 SGD · the 4.10 SGD price screens above the 1.99 SGD fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Parkway Life Real Estate Investment Trust (C2PU) currently trades at 4.10 SGD, while our model-based Fair Value estimate is 1.99 SGD — implying the stock looks roughly 51.5% overvalued today. We read business quality at 57/100 (solid quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Trailing-twelve-month revenue stands at 155M SGD. Revenue declined 2.1% year over year. It earns a return on equity of 10.0%. Net debt stands at 836M SGD. Fundamentals as of Jul 4, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
Parkway Life Real Estate Investment Trust is a unit trust constituted pursuant to the trust deed (as amended) (the Trust Deed) between Parkway Trust Management Limited (the Manager) and HSBC Institutional Trust Services (Singapore) Limited (the Trustee). On 12 July 2007, the Trust was declared as an authorized unit trust scheme under the Trustees Act, Chapter 337. The Trustee is under a duty to take into custody and hold the assets of the Trust and its subsidiaries (the Group) in trust for the holders (Unitholders) of units in the Trust. On 23 August 2007, the Trust was admitted to the Official List of the Singapore Exchange Securities Trading Limited and was included under the Central Provident Fund Investment Scheme on the same date. The principal activity of the Trust is to invest primarily in income-producing real estate and/or real estate-related assets in the Asia-Pacific region (including Singapore) that are used primarily for healthcare and/or healthcare-related purposes …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Parkway Life Real Estate Investment Trust reported revenue of 156M SGD in FY2025 versus 121M SGD in FY2021, a compound +6.6%/yr. Reported net income was 153M SGD in FY2025, compounding −17.6%/yr from FY2021.
Is C2PU fairly valued? → Check now
Similar stocks
6 more REIT - Healthcare Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Welltower Inc WELL | $211.45 | $48.83 | -77% |
| Ventas, Inc VTR | $86.57 | $18.07 | -79% |
| Omega Healthcare Investors, Inc OHI | $47.62 | $33.69 | -29% |
| Healthpeak Properties, Inc DOC | $19.56 | $16.40 | -16% |
| American Healthcare REIT, Inc AHR | $48.67 | $11.04 | -77% |
| CareTrust REIT, Inc CTRE | $38.80 | $26.87 | -31% |
Explore undervalued stocks
More undervalued Real Estate stocks →
Frequently asked questions
Is Parkway Life Real Estate Investment Trust (C2PU) undervalued?
What is the fair value of C2PU?
What is the quality score of C2PU?
What is the revenue of Parkway Life Real Estate Investment Trust (C2PU)?
What is the net profit margin of C2PU?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.